Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Bell JSK"'
Autor:
Ingale K; Tempus AI, Inc., Chicago, Illinois., Hong SH; Tempus AI, Inc., Chicago, Illinois., Bell JSK; Tempus AI, Inc., Chicago, Illinois., Rizvi A; Tempus AI, Inc., Chicago, Illinois., Welch A; Tempus AI, Inc., Chicago, Illinois., Sha L; Tempus AI, Inc., Chicago, Illinois., Ho I; Tempus AI, Inc., Chicago, Illinois., Nagpal K; Tempus AI, Inc., Chicago, Illinois., Bentaieb A; Tempus AI, Inc., Chicago, Illinois., Joshi RP; Tempus AI, Inc., Chicago, Illinois. Electronic address: rohan.joshi@tempus.com., Stumpe MC; Tempus AI, Inc., Chicago, Illinois.
Publikováno v:
The American journal of pathology [Am J Pathol] 2024 Jun; Vol. 194 (6), pp. 1020-1032. Date of Electronic Publication: 2024 Mar 15.
Autor:
Blas PE; Clinical Oncology Research Coordination, Baylor Scott and White Research Institute, Dallas, Texas, USA., Rodriguez ESR; Clinical Oncology Research Coordination, Baylor Scott and White Research Institute, Dallas, Texas, USA., Williams HL; Clinical Oncology Research Coordination, Baylor Scott and White Research Institute, Dallas, Texas, USA., Levin MK; Clinical Oncology Research Coordination, Baylor Scott and White Research Institute, Dallas, Texas, USA., Bell JSK; Department of Translational Science, Tempus Labs Inc., Chicago, Illinois, USA., Pierobon M; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia, USA., Barrett AS; Department of Translational Science, Tempus Labs Inc., Chicago, Illinois, USA., Petricoin EF; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia, USA., O'Shaughnessy JA; Breast Cancer Research Program, Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, Texas, USA.
Publikováno v:
Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2024 Mar; Vol. 7 (3), pp. e1954.
Autor:
Jhaveri K; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York; Weill Cornell Medical College, New York. Electronic address: jhaverik@mskcc.org., Eli LD; Clinical Development, Puma Biotechnology, Los Angeles, USA., Wildiers H; University Hospitals Leuven, Leuven, Belgium., Hurvitz SA; David Geffen School of Medicine, UCLA, Los Angeles, Santa Monica, USA., Guerrero-Zotano A; Medical Oncology Department, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Unni N; UT Southwestern Medical Center, Dallas., Brufsky A; Magee-Womens Hospital of UPMC, Pittsburgh., Park H; Washington University School of Medicine, St. Louis., Waisman J; City of Hope Comprehensive Cancer Center, Duarte., Yang ES; University of Alabama at Birmingham, Birmingham, USA., Spanggaard I; Department of Oncology, Rigshospitalet - Copenhagen University Hospital, Copenhagen, Denmark., Reid S; Division of Hematology/Oncology (Breast Oncology), The Vanderbilt-Ingram Cancer Center, Nashville., Burkard ME; Division of Hematology/Oncology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison., Vinayak S; Seattle Cancer Care Alliance, Seattle, USA., Prat A; Hospital Clínic de Barcelona, Barcelona, Spain., Arnedos M; Department of Medical Oncology, Gustave Roussy, Villejuif., Bidard FC; Department of Medical Oncology, UVSQ/Paris-Saclay University, Institut Curie, Saint Cloud, France., Loi S; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, Australia., Crown J; St. Vincent's University Hospital, Dublin, Ireland., Bhave M; Department of Hematology/Oncology, Emory University, Winship Cancer Institute, Atlanta., Piha-Paul SA; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston., Suga JM; Kaiser Permanente, Department of Medical Oncology, Vallejo, USA., Chia S; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada., Saura C; Medical Oncology Service, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona., Garcia-Saenz JÁ; Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), CIBERONC, Madrid., Gambardella V; Hospital Clínico de Valencia, Instituto de Investigación Sanitaria INCLIVA, Valencia., de Miguel MJ; START Madrid - Hospital Universitario Madrid Sanchinarro, Madrid, Spain., Gal-Yam EN; Institute of Breast Oncology, Sheba Medical Center, Ramat Gan., Rapael A; Sourasky Medical Center, Tel Aviv., Stemmer SM; Davidoff Cancer Center, Rabin Medical Center, Petah Tikva; Tel Aviv University, Tel Aviv, Israel., Ma C; Division of Medical Oncology, Department of Medicine and Siteman Cancer Center, Washington University, St. Louis., Hanker AB; UT Southwestern Simmons Comprehensive Cancer Center, Dallas., Ye D; UT Southwestern Simmons Comprehensive Cancer Center, Dallas., Goldman JW; UCLA Hematology & Oncology, Santa Monica., Bose R; Division of Medical Oncology, Department of Medicine and Siteman Cancer Center, Washington University, St. Louis., Peterson L; Division of Medical Oncology, Department of Medicine and Siteman Cancer Center, Washington University, St. Louis., Bell JSK; Tempus Labs, Chicago, USA., Frazier A; Clinical Development, Puma Biotechnology, Los Angeles, USA., DiPrimeo D; Clinical Development, Puma Biotechnology, Los Angeles, USA., Wong A; Clinical Development, Puma Biotechnology, Los Angeles, USA., Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas., Solit DB; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 Oct; Vol. 34 (10), pp. 885-898. Date of Electronic Publication: 2023 Aug 18.
Autor:
Miyashita M; The University of Chicago, Chicago, IL, USA., Bell JSK; Tempus Inc, Chicago, IL, USA., Wenric S; Tempus Inc, Chicago, IL, USA., Karaesmen E; Tempus Inc, Chicago, IL, USA., Rhead B; Tempus Inc, Chicago, IL, USA., Kase M; Tempus Inc, Chicago, IL, USA., Kaneva K; Tempus Inc, Chicago, IL, USA., De La Vega FM; Tempus Inc, Chicago, IL, USA., Zheng Y; The University of Chicago, Chicago, IL, USA., Yoshimatsu TF; The University of Chicago, Chicago, IL, USA., Khramtsova G; The University of Chicago, Chicago, IL, USA., Liu F; The University of Chicago, Chicago, IL, USA., Zhao F; The University of Chicago, Chicago, IL, USA., Howard FM; The University of Chicago, Chicago, IL, USA., Nanda R; The University of Chicago, Chicago, IL, USA., Beaubier N; Tempus Inc, Chicago, IL, USA., White KP; Tempus Inc, Chicago, IL, USA.; National University Singapore, Queenstown, Singapore., Huo D; The University of Chicago, Chicago, IL, USA., Olopade OI; The University of Chicago, Chicago, IL, USA. folopade@bsd.uchicago.edu.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2023 May 25; Vol. 25 (1), pp. 58. Date of Electronic Publication: 2023 May 25.
Autor:
Zhao F; Department of Public Health Sciences, University of Chicago, Chicago, Illinois., Miyashita M; Department of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.; Section of Hematology and Oncology, Department of Medicine, Knapp Center for Biomedical Discovery, University of Chicago, Chicago, Illinois., Hattori M; Department of Breast Oncology, Aichi Cancer Center, Nagoya, Japan., Yoshimatsu T; Section of Hematology and Oncology, Department of Medicine, Knapp Center for Biomedical Discovery, University of Chicago, Chicago, Illinois., Howard F; Section of Hematology and Oncology, Department of Medicine, Knapp Center for Biomedical Discovery, University of Chicago, Chicago, Illinois., Kaneva K; Tempus Inc, Chicago, Illinois., Jones R; Tempus Inc, Chicago, Illinois., Bell JSK; Tempus Inc, Chicago, Illinois., Fleming GF; Section of Hematology and Oncology, Department of Medicine, Knapp Center for Biomedical Discovery, University of Chicago, Chicago, Illinois., Jaskowiak N; Department of Surgery, University of Chicago, Chicago, Illinois., Nanda R; Section of Hematology and Oncology, Department of Medicine, Knapp Center for Biomedical Discovery, University of Chicago, Chicago, Illinois., Zheng Y; Section of Hematology and Oncology, Department of Medicine, Knapp Center for Biomedical Discovery, University of Chicago, Chicago, Illinois., Huo D; Department of Public Health Sciences, University of Chicago, Chicago, Illinois.; Section of Hematology and Oncology, Department of Medicine, Knapp Center for Biomedical Discovery, University of Chicago, Chicago, Illinois., Olopade OI; Section of Hematology and Oncology, Department of Medicine, Knapp Center for Biomedical Discovery, University of Chicago, Chicago, Illinois.
Publikováno v:
JAMA network open [JAMA Netw Open] 2023 Mar 01; Vol. 6 (3), pp. e233329. Date of Electronic Publication: 2023 Mar 01.
Autor:
Leibowitz BD; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Dougherty BV; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Bell JSK; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Kapilivsky J; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Michuda J; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Sedgewick AJ; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Munson WA; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Chandra TA; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Dry JR; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Beaubier N; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Igartua C; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Taxter T; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States. tim@tempus.com.
Publikováno v:
BMC cancer [BMC Cancer] 2022 May 28; Vol. 22 (1), pp. 587. Date of Electronic Publication: 2022 May 28.
Autor:
Fernandes LE; Tempus Labs, Chicago, IL., Epstein CG; Tempus Labs, Chicago, IL., Bobe AM; Tempus Labs, Chicago, IL., Bell JSK; Tempus Labs, Chicago, IL., Stumpe MC; Tempus Labs, Chicago, IL., Salazar ME; Tempus Labs, Chicago, IL., Salahudeen AA; Tempus Labs, Chicago, IL., Pe Benito RA; Tempus Labs, Chicago, IL., McCarter C; Tempus Labs, Chicago, IL., Leibowitz BD; Tempus Labs, Chicago, IL., Kase M; Tempus Labs, Chicago, IL., Igartua C; Tempus Labs, Chicago, IL., Huether R; Tempus Labs, Chicago, IL., Hafez A; Tempus Labs, Chicago, IL., Beaubier N; Tempus Labs, Chicago, IL., Axelson MD; Tempus Labs, Chicago, IL., Pegram MD; Stanford Comprehensive Cancer Institute, Stanford University School of Medicine, Stanford, CA., Sammons SL; Department of Medicine, Duke University Medical Center, Duke University, Durham, NC., O'Shaughnessy JA; Baylor University Medical Center, Texas Oncology and US Oncology, Dallas, TX., Palmer GA; Tempus Labs, Chicago, IL. Electronic address: publications@Tempus.com.
Publikováno v:
Clinical breast cancer [Clin Breast Cancer] 2021 Aug; Vol. 21 (4), pp. e340-e361. Date of Electronic Publication: 2020 Dec 18.
Autor:
Summerbell ER; Graduate Program in Cancer Biology, Emory University, Atlanta, GA, USA., Mouw JK; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA.; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Bell JSK; Graduate Program in Genetics and Molecular Biology, Emory University, Atlanta, GA, USA., Knippler CM; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA.; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Pedro B; Graduate Program in Cancer Biology, Emory University, Atlanta, GA, USA., Arnst JL; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA.; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Khatib TO; Graduate Program in Biochemistry, Cell and Developmental Biology, Emory University, Atlanta, GA, USA., Commander R; Graduate Program in Cancer Biology, Emory University, Atlanta, GA, USA., Barwick BG; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA.; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Konen J; Graduate Program in Cancer Biology, Emory University, Atlanta, GA, USA., Dwivedi B; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Seby S; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Kowalski J; Winship Cancer Institute, Emory University, Atlanta, GA, USA.; Department of Biostatistics and Bioinformatics, Emory University, Atlanta, GA, USA., Vertino PM; Winship Cancer Institute, Emory University, Atlanta, GA, USA.; Department of Radiation Oncology, Emory University, Atlanta, GA, USA., Marcus AI; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA.; Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Publikováno v:
Science advances [Sci Adv] 2020 Jul 24; Vol. 6 (30), pp. eaaz6197. Date of Electronic Publication: 2020 Jul 24 (Print Publication: 2020).
Autor:
Kennedy EM; Graduate Program in Genetics and Molecular Biology, Emory University, Atlanta, GA, 30322, USA.; Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, 30322, USA., Powell DR; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, 30322, USA., Li Z; Department of Biochemistry, Emory University School of Medicine, Atlanta, GA, 30322, USA., Bell JSK; Graduate Program in Genetics and Molecular Biology, Emory University, Atlanta, GA, 30322, USA.; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, 30322, USA.; Department of Medicine, University of Chicago, Chicago, IL, USA., Barwick BG; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, 30322, USA., Feng H; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, 30322, USA., McCrary MR; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, 30322, USA., Dwivedi B; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, 30322, USA., Kowalski J; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, 30322, USA.; Winship Cancer Institute of Emory University, Atlanta, GA, 30322, USA., Dynan WS; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, 30322, USA.; Department of Biochemistry, Emory University School of Medicine, Atlanta, GA, 30322, USA.; Winship Cancer Institute of Emory University, Atlanta, GA, 30322, USA., Conneely KN; Graduate Program in Genetics and Molecular Biology, Emory University, Atlanta, GA, 30322, USA.; Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, 30322, USA.; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, 30322, USA., Vertino PM; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, 30322, USA. pvertin@emory.edu.; Winship Cancer Institute of Emory University, Atlanta, GA, 30322, USA. pvertin@emory.edu.
Publikováno v:
Scientific reports [Sci Rep] 2018 Apr 30; Vol. 8 (1), pp. 6709. Date of Electronic Publication: 2018 Apr 30.
Autor:
Bell JSK; a Department of Radiation Oncology , Emory University School of Medicine , Atlanta , GA , USA.; b Winship Cancer Institute of Emory University , Atlanta , GA , USA.; c Graduate Program in Genetics & Molecular Biology , Emory University , Atlanta , GA, USA., Vertino PM; a Department of Radiation Oncology , Emory University School of Medicine , Atlanta , GA , USA.; b Winship Cancer Institute of Emory University , Atlanta , GA , USA.
Publikováno v:
Epigenetics [Epigenetics] 2017 Jun 03; Vol. 12 (6), pp. 449-464. Date of Electronic Publication: 2017 Apr 27.